Compare PRLB & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRLB | INSP |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | 2280 | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2011 | 2018 |
| Metric | PRLB | INSP |
|---|---|---|
| Price | $72.13 | $40.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 16 |
| Target Price | $53.00 | ★ $94.00 |
| AVG Volume (30 Days) | 140.1K | ★ 1.0M |
| Earning Date | 05-01-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.33 | ★ 179.43 |
| EPS | ★ 0.33 | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $8.56 | $8.02 |
| Revenue Next Year | $6.89 | $8.11 |
| P/E Ratio | $219.32 | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $36.15 | $41.52 |
| 52 Week High | $73.11 | $152.36 |
| Indicator | PRLB | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 73.89 | 27.58 |
| Support Level | $47.69 | N/A |
| Resistance Level | N/A | $59.40 |
| Average True Range (ATR) | 3.21 | 2.74 |
| MACD | 0.55 | -1.04 |
| Stochastic Oscillator | 94.95 | 3.06 |
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. The Lab uses injection molding, computer numerical control machining, and 3-D printing, and sheet metal to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.